Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis

• René M. Gieß,

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Catherina Pfuhl,

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Janina R. Behrens,

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Ludwig Rasche,

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Erik Freitag,

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Nima Khalighy,

  Affiliation Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Carolin Otto,

  Affiliation St. Josefs-Krankenhaus, Potsdam, Germany

  ⨯
• Jens Wuerfel,

  Affiliations NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, MIAC AG and Dep. for Biomedical Engineering, University of Basel, Basel, Switzerland

  ⨯
• Alexander U. Brandt,

  Affiliations NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Jörg Hofmann,

  Affiliations Labor Berlin Charité-Vivantes GmbH, Berlin, Germany, Institute of Medical Virology, Charité –Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Bettina Eberspächer,

  Affiliations Labor Berlin Charité-Vivantes GmbH, Berlin, Germany, Vivantes Klinikum Neukölln, Berlin, Germany

  ⨯
• Judith Bellmann-Strobl,

  Affiliations NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany

  ⨯
• Friedemann Paul,

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany, Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany

  ⨯
• Klemens Ruprecht

  * E-mail: klemens.ruprecht@charite.de

  Affiliations Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany, Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany

  http://orcid.org/0000-0003-1962-6014

  ⨯